US

BridgeBio Pharma nets $135 mln

Palo Alto, California-based BridgeBio Pharma, a clinical-stage biopharmaceutical company, has raised $135 million in funding. Viking Global Investors and KKR led the round with participation from Perceptive Advisors, AIG, Aisling Capital, Cormorant Capital and Janus Funds.

Credly pulls in $4.6 mln

New York City-based Credly, a digital credential platform, has raised $4.6 million in funding. Credly's investors include New Markets Venture Partners, University Ventures, Lumina Foundation, City & Guilds Group and Lion Brothers.

Swiss health tech company Sophia Genetics lands $30 mln Series D

Sophia Genetics, a Swiss health tech company, has secured $30 million in Series D funding. Balderton Capital led the round with participation from 360º Capital Partners, Invoke Capital and Alychlo.

Infostellar snags $7.3 mln Series A

Tokyo-based Infostellar, a space communications infrastructure firm, has raised $7.3 million in Series A funding. Airbus Ventures led the round with participation from WERU Investment, D4V, Sony Innovation Fund, FreakOut Holdings and 500 Startups Japan.

dv01 grabs $5.5 mln Series A

New York-based dv01, a lending markets analytics platform, has secured $5.5 million in Series A funding. OCA Ventures. Ribbit Capital, Illuminate Financial and CreditEase Fintech Investment Fund led the round with participation from Leucadia National Corporation and Pivot Investment Partners. In addition to the funding, OCA adviser Jack Lavin has joined dv01's board.

Khosla Vetures leads Series A round for Ori

Ori Inc, a provider of an "intelligent, responsive systems that enable the elegant and effortless transformation of interior space," has raised $6 million in Series A funding. Khosla Ventures led the round.

Heptio picks up $25 mln Series B

Seattle-based Heptio, which is built to support and advance the open Kubernetes ecosystem, has raised $25 million in Series B funding. Madrona Venture Group led the round with participation from Lightspeed Venture Partners and Accel Partners.

Braavo Capital closes $70 mln of debt, equity financing

Braavo Capital said it raised debt and equity financing of more than $70 million dollars in a deal led by existing investor Mark 2 Capital and joined by angel investors and family offices.

Bain Capital Ventures names Snider as ExIR

David Snider is joining Bain Capital Ventures as the firm's new executive-in-residence, according to a blog post by Managing Director Matt Harris. Snider is the former chief financial officer at Compass. He previously worked at Bain as a private equity associate from 2009 to 2011.

Paragon Genomics reels in $8 mln Series A

Hayward, California-based Paragon Genomics, a life science company, has raised $8 million in Series A funding. Cowin Venture Capital and Fosun Industrial Co led the round with participation from Cloudstone Venture, HEDA Ventures and Wisemont Capital.